Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Reactive oxygen species (ROS) homeostatic pathways in microbes operate instant and feedback-regulated adjustments of intracellular ROS concentration. They use redox sensors that 'measure' ROS ...